The University of Southampton
×
Filter your search:
University of Southampton Institutional Repository

To evaluate a protocol for prompt migration from an unlicensed to a licensed product using the NHS change model in a paediatric cardiology setting

To evaluate a protocol for prompt migration from an unlicensed to a licensed product using the NHS change model in a paediatric cardiology setting
To evaluate a protocol for prompt migration from an unlicensed to a licensed product using the NHS change model in a paediatric cardiology setting
The use of unlicensed medicines for infants and children is a well documented issue. A review in five hospitals showed over half of prescriptions were either unlicensed or off-label.1 A marketing authorisation (also known as licensing) decision in medicine is based on a judgement that benefits outweigh the potential risks. Furthermore a licensed medication has been assessed for efficacy, safety and quality; has been manufactured to appropriate quality standards; and when placed on the market is accompanied by appropriate product information and labelling.
0003-9888
29
Olalekan, Kazeem, Babatunde
76a8cf63-1365-45b4-ad42-099d78e4bd85
Cole, Caroline
8ed1008e-d8a5-4d82-a6e5-9c21373dfaeb
Olalekan, Kazeem, Babatunde
76a8cf63-1365-45b4-ad42-099d78e4bd85
Cole, Caroline
8ed1008e-d8a5-4d82-a6e5-9c21373dfaeb

Olalekan, Kazeem, Babatunde and Cole, Caroline (2015) To evaluate a protocol for prompt migration from an unlicensed to a licensed product using the NHS change model in a paediatric cardiology setting. Archives of Disease in Childhood, 29. (doi:10.1136/archdischild-2015-308634.37).

Record type: Meeting abstract

Abstract

The use of unlicensed medicines for infants and children is a well documented issue. A review in five hospitals showed over half of prescriptions were either unlicensed or off-label.1 A marketing authorisation (also known as licensing) decision in medicine is based on a judgement that benefits outweigh the potential risks. Furthermore a licensed medication has been assessed for efficacy, safety and quality; has been manufactured to appropriate quality standards; and when placed on the market is accompanied by appropriate product information and labelling.

This record has no associated files available for download.

More information

Published date: 1 June 2015
Venue - Dates: Neonatal and Paediatric Pharmacists Group (NPPG) 20th Annual Conference, 2014-11-07 - 2014-11-09

Identifiers

Local EPrints ID: 412979
URI: http://eprints.soton.ac.uk/id/eprint/412979
DOI: doi:10.1136/archdischild-2015-308634.37
ISSN: 0003-9888
PURE UUID: e419afe4-91c9-4cb4-bff4-06ebb00b005c
ORCID for Kazeem, Babatunde Olalekan: ORCID iD orcid.org/0000-0001-7666-7117

Catalogue record

Date deposited: 10 Aug 2017 16:30
Last modified: 15 Mar 2024 15:33

Export record

Altmetrics

Contributors

Author: Kazeem, Babatunde Olalekan ORCID iD
Author: Caroline Cole

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Library staff additional information
Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×